舌下神經刺激治療阻塞性睡眠呼吸暫停低通氣綜合征的研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

張榮麗 , 王微 , 褚堯 ,  余勤

蘭州大學第一臨床醫學院（甘肅蘭州 730000）;

Corresponding?author：

余勤, Email: yuq701@163.com

Keywords：

DOI：

10.7507/1671-6205.201808014

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 張榮麗, 王微, 褚堯, 余勤. 舌下神經刺激治療阻塞性睡眠呼吸暫停低通氣綜合征的研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2019, 18(4): 400-403. doi: 10.7507/1671-6205.201808014 Copy

1.	Grote L, Ploch T, Heitmann J, et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Resp Crit Care, 1999, 160(6): 1875-1882.
2.	Sawatari H, Chishaki A, Ando SI. The epidemiology of sleep disordered breathing and hypertension in various populations. Curr Hypertens Rev, 2016, 12(1): 12-17.
3.	Parra O, Arboix A, Montserrat JM, et al. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J, 2004, 24(2): 267-272.
4.	Sahlin C, Sandberg O, Gustafson Y, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke. Arch Intern Med, 2008, 168(3): 297-301.
5.	Ip MSM, Lam B, Ng MMT, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Resp Crit Care, 2002, 165(5): 670-676.
6.	Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005, 365(9464): 1046-1053.
7.	Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. New Engl J Med, 2005, 353(19): 2034-2041.
8.	Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Resp Crit Care, 2001, 163(3): 685-689.
9.	Peker Y, Glantz H, Eulenburg C, et al. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA Randomized Controlled Trial. Am J Resp Crit Care, 2016, 194(5): 613-620.
10.	Miki H, Hida W, Shindoh C, et al. Effects of electrical stimulation of the genioglossus on upper airway resistance in anesthetized dogs. Am Rev Respir Dis, 1989, 140(5): 1279-1284.
11.	Schwartz AR, Thut DC, Russ B, et al. Effect of electrical stimulation of the hypoglossal nerve on airflow mechanics in the isolated upper airway. Am Rev Respir Dis, 1993, 147(5): 1144-1150.
12.	Bellemare F, Pecchiari M, Bandini M, et al. Reversibility of airflow obstruction by hypoglossus nerve stimulation in anesthetized rabbits. Am J Respir Crit Care Med, 2005, 172(5): 606-612.
13.	Goding GS Jr, Eisele DW, Testerman R, et al. Relief of upper airway obstruction with hypoglossal nerve stimulation in the canine. Laryngoscope, 1998, 108(2): 162-169.
14.	Schwartz AR, Bennett ML, Smith PL, et al. Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Arch Otolaryngol Head Neck Surg, 2001, 127(10): 1216-1223.
15.	Zaidi FN, Meadows P, Jacobowitz O, et al. Tongue anatomy and physiology, the scientific basis for a novel targeted neurostimulation system designed for the treatment of obstructive sleep apnea. Neuromodulation, 2013, 16(4): 376-386.
16.	Friedman M, Jacobowitz O, Hwang MS, et al. Targeted hypoglossal nerve stimulation for the treatment of obstructive sleep apnea: six-month results. Laryngoscope, 2016, 126(11): 2618-2623.
17.	Strohl MDK, Baskin MDJ, Lance MDC, et al. Origins of and implementation concepts for upper airway stimulation therapy for obstructive sleep apnea. Respir Investig, 2016, 54(4): 241-249.
18.	Van de Heyning PH, Badr MS, Baskin JZ, et al. Implanted upper airway stimulation device for obstructive sleep apnea. Laryngoscope, 2012, 122(7): 1626-1633.
19.	Steffen A, Frenzel H, Wollenberg B, et al. Patient selection for upper airway stimulation: is concentric collapse in sleep endoscopy predictable?. Sleep Breath, 2015, 19(4): 1373-1376.
20.	Hasselbacher K, Bruchhage KL, Abrams N, et al. [Sleep endoscopy and complete concentric collapse in CPAP failure]. HNO, 2018, 66(11): 837-842.
21.	Huntley C, Kaffenberger T, Doghramji K, et al. Upper airway stimulation for treatment of obstructive sleep apnea: an evaluation and comparison of outcomes at two academic centers. J Clin Sleep Med, 2017, 13(9): 1075-1079.
22.	Steffen A, Sommer JU, Hofauer B, et al. Outcome after one year of upper airway stimulation for obstructive sleep apnea in a Multicenter German Post-Market Study. Laryngoscope, 2018, 128(2): 509-515.
23.	Boon M, Huntley C, Steffen A, et al. Upper airway stimulation for obstructive sleep apnea: results from the ADHERE Registry. Otolaryngol Head Neck Surg, 2018, 159(2): 379-385.
24.	Strollo PJ Jr, Soose RJ, Maurer JT, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med, 2014, 370(2): 139-149.
25.	Gillespie MB, Soose RJ, Woodson BT, et al. Upper airway stimulation for obstructive sleep apnea: patient-reported outcomes after 48 months of follow-up. Otolaryngol Head Neck Surg, 2017, 156(4): 765-771.
26.	Woodson BT, Soose RJ, Gillespie MB, et al. Three-year outcomes of cranial nerve stimulation for obstructive sleep apnea: The STAR Trial. Otolaryngol Head Neck Surg, 2016, 154(1): 181-188.
27.	Woodson BT, Strohl KP, Soose RJ, et al. Upper airway stimulation for obstructive sleep apnea: 5-year outcomes. Otolaryngol Head Neck Surg, 2018, 159(1): 194-202.
28.	Hofauer B, Steffen A, Knopf A, et al. Adherence to upper-airway stimulation in the treatment of OSA. Chest, 2018, 153(2): 574-575.
29.	Hofauer B, Philip P, Wirth M, et al. Effects of upper-airway stimulation on sleep architecture in patients with obstructive sleep apnea. Sleep Breath, 2017, 21(4): 901-908.
30.	Philip P, Heiser C, Bioulac S, et al. Hypoglossal nerve stimulation on sleep and level of alertness in OSA. A preliminary study, 2018, 91(7): e615-e619.
31.	Mwenge GB, Rombaux P, Dury M, et al. Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study. Eur Respir J, 2013, 41(2): 360-367.
32.	Schwartz AR, Barnes M, Hillman D, et al. Acute upper airway responses to hypoglossal nerve stimulation during sleep in obstructive sleep apnea. Am J Respir Crit Care Med, 2012, 185(4): 420-426.
33.	Safiruddin F, Vanderveken OM, de Vries N, et al. Effect of upper-airway stimulation for obstructive sleep apnoea on airway dimensions. Eur Respir J, 2015, 45(1): 129-138.
34.	Schwab RJ, Wang SH, Verbraecken J, et al. Anatomic predictors of response and mechanism of action of upper airway stimulation therapy in patients with obstructive sleep apnea. Sleep, 2018, 41(4).
35.	Heiser C, Thaler E, Boon M, et al. Updates of operative techniques for upper airway stimulation. Laryngoscope, 2016, 126(S7): S12-S16.
36.	Arteaga AA, Pitts KD, Lewis AF. Iatrogenic pneumothorax during hypoglossal nerve stimulator implantation. Am J Otolaryng, 2018, 39(5): 636-638.
37.	Diercks GR, Wentland C, Keamy D, et al. Hypoglossal nerve stimulation in adolescents with down syndrome and obstructive sleep apnea. JAMA Otolaryngol Head Neck Surg, 2017, 144(1): 37-42.
38.	Parikh V, Thaler E, Kato M, et al. Early feasibility of hypoglossal nerve upper airway stimulator in patients with cardiac implantable electronic devices and continuous positive airway pressure-intolerant severe obstructive sleep apnea. Heart Rhythm, 2018, 15(8): 1165-1170.
39.	Seo J, Wee JH, Park JH, et al. Nerve cuff electrode using embedded magnets and its application to hypoglossal nerve stimulation. J Neural Eng, 2016, 13(6): 066014.

1. Grote L, Ploch T, Heitmann J, et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Resp Crit Care, 1999, 160(6): 1875-1882.
2. Sawatari H, Chishaki A, Ando SI. The epidemiology of sleep disordered breathing and hypertension in various populations. Curr Hypertens Rev, 2016, 12(1): 12-17.
3. Parra O, Arboix A, Montserrat JM, et al. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J, 2004, 24(2): 267-272.
4. Sahlin C, Sandberg O, Gustafson Y, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke. Arch Intern Med, 2008, 168(3): 297-301.
5. Ip MSM, Lam B, Ng MMT, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Resp Crit Care, 2002, 165(5): 670-676.
6. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005, 365(9464): 1046-1053.
7. Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. New Engl J Med, 2005, 353(19): 2034-2041.
8. Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Resp Crit Care, 2001, 163(3): 685-689.
9. Peker Y, Glantz H, Eulenburg C, et al. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA Randomized Controlled Trial. Am J Resp Crit Care, 2016, 194(5): 613-620.
10. Miki H, Hida W, Shindoh C, et al. Effects of electrical stimulation of the genioglossus on upper airway resistance in anesthetized dogs. Am Rev Respir Dis, 1989, 140(5): 1279-1284.
11. Schwartz AR, Thut DC, Russ B, et al. Effect of electrical stimulation of the hypoglossal nerve on airflow mechanics in the isolated upper airway. Am Rev Respir Dis, 1993, 147(5): 1144-1150.
12. Bellemare F, Pecchiari M, Bandini M, et al. Reversibility of airflow obstruction by hypoglossus nerve stimulation in anesthetized rabbits. Am J Respir Crit Care Med, 2005, 172(5): 606-612.
13. Goding GS Jr, Eisele DW, Testerman R, et al. Relief of upper airway obstruction with hypoglossal nerve stimulation in the canine. Laryngoscope, 1998, 108(2): 162-169.
14. Schwartz AR, Bennett ML, Smith PL, et al. Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Arch Otolaryngol Head Neck Surg, 2001, 127(10): 1216-1223.
15. Zaidi FN, Meadows P, Jacobowitz O, et al. Tongue anatomy and physiology, the scientific basis for a novel targeted neurostimulation system designed for the treatment of obstructive sleep apnea. Neuromodulation, 2013, 16(4): 376-386.
16. Friedman M, Jacobowitz O, Hwang MS, et al. Targeted hypoglossal nerve stimulation for the treatment of obstructive sleep apnea: six-month results. Laryngoscope, 2016, 126(11): 2618-2623.
17. Strohl MDK, Baskin MDJ, Lance MDC, et al. Origins of and implementation concepts for upper airway stimulation therapy for obstructive sleep apnea. Respir Investig, 2016, 54(4): 241-249.
18. Van de Heyning PH, Badr MS, Baskin JZ, et al. Implanted upper airway stimulation device for obstructive sleep apnea. Laryngoscope, 2012, 122(7): 1626-1633.
19. Steffen A, Frenzel H, Wollenberg B, et al. Patient selection for upper airway stimulation: is concentric collapse in sleep endoscopy predictable?. Sleep Breath, 2015, 19(4): 1373-1376.
20. Hasselbacher K, Bruchhage KL, Abrams N, et al. [Sleep endoscopy and complete concentric collapse in CPAP failure]. HNO, 2018, 66(11): 837-842.
21. Huntley C, Kaffenberger T, Doghramji K, et al. Upper airway stimulation for treatment of obstructive sleep apnea: an evaluation and comparison of outcomes at two academic centers. J Clin Sleep Med, 2017, 13(9): 1075-1079.
22. Steffen A, Sommer JU, Hofauer B, et al. Outcome after one year of upper airway stimulation for obstructive sleep apnea in a Multicenter German Post-Market Study. Laryngoscope, 2018, 128(2): 509-515.
23. Boon M, Huntley C, Steffen A, et al. Upper airway stimulation for obstructive sleep apnea: results from the ADHERE Registry. Otolaryngol Head Neck Surg, 2018, 159(2): 379-385.
24. Strollo PJ Jr, Soose RJ, Maurer JT, et al. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med, 2014, 370(2): 139-149.
25. Gillespie MB, Soose RJ, Woodson BT, et al. Upper airway stimulation for obstructive sleep apnea: patient-reported outcomes after 48 months of follow-up. Otolaryngol Head Neck Surg, 2017, 156(4): 765-771.
26. Woodson BT, Soose RJ, Gillespie MB, et al. Three-year outcomes of cranial nerve stimulation for obstructive sleep apnea: The STAR Trial. Otolaryngol Head Neck Surg, 2016, 154(1): 181-188.
27. Woodson BT, Strohl KP, Soose RJ, et al. Upper airway stimulation for obstructive sleep apnea: 5-year outcomes. Otolaryngol Head Neck Surg, 2018, 159(1): 194-202.
28. Hofauer B, Steffen A, Knopf A, et al. Adherence to upper-airway stimulation in the treatment of OSA. Chest, 2018, 153(2): 574-575.
29. Hofauer B, Philip P, Wirth M, et al. Effects of upper-airway stimulation on sleep architecture in patients with obstructive sleep apnea. Sleep Breath, 2017, 21(4): 901-908.
30. Philip P, Heiser C, Bioulac S, et al. Hypoglossal nerve stimulation on sleep and level of alertness in OSA. A preliminary study, 2018, 91(7): e615-e619.
31. Mwenge GB, Rombaux P, Dury M, et al. Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study. Eur Respir J, 2013, 41(2): 360-367.
32. Schwartz AR, Barnes M, Hillman D, et al. Acute upper airway responses to hypoglossal nerve stimulation during sleep in obstructive sleep apnea. Am J Respir Crit Care Med, 2012, 185(4): 420-426.
33. Safiruddin F, Vanderveken OM, de Vries N, et al. Effect of upper-airway stimulation for obstructive sleep apnoea on airway dimensions. Eur Respir J, 2015, 45(1): 129-138.
34. Schwab RJ, Wang SH, Verbraecken J, et al. Anatomic predictors of response and mechanism of action of upper airway stimulation therapy in patients with obstructive sleep apnea. Sleep, 2018, 41(4).
35. Heiser C, Thaler E, Boon M, et al. Updates of operative techniques for upper airway stimulation. Laryngoscope, 2016, 126(S7): S12-S16.
36. Arteaga AA, Pitts KD, Lewis AF. Iatrogenic pneumothorax during hypoglossal nerve stimulator implantation. Am J Otolaryng, 2018, 39(5): 636-638.
37. Diercks GR, Wentland C, Keamy D, et al. Hypoglossal nerve stimulation in adolescents with down syndrome and obstructive sleep apnea. JAMA Otolaryngol Head Neck Surg, 2017, 144(1): 37-42.
38. Parikh V, Thaler E, Kato M, et al. Early feasibility of hypoglossal nerve upper airway stimulator in patients with cardiac implantable electronic devices and continuous positive airway pressure-intolerant severe obstructive sleep apnea. Heart Rhythm, 2018, 15(8): 1165-1170.
39. Seo J, Wee JH, Park JH, et al. Nerve cuff electrode using embedded magnets and its application to hypoglossal nerve stimulation. J Neural Eng, 2016, 13(6): 066014.

Previous Article
血嗜酸性粒細胞在慢性阻塞性肺疾病的臨床研究進展
Next Article
炎性小體在肺部疾病中的作用

Chinese Journal of Respiratory and Critical Care Medicine

舌下神經刺激治療阻塞性睡眠呼吸暫停低通氣綜合征的研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content